Luye Pharma Group (FRA:LUP) Buildings And Improvements : €358.0 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Luye Pharma Group Buildings And Improvements?

Luye Pharma Group's quarterly buildings and improvements declined from Dec. 2023 (€272.1 Mil) to Jun. 2024 (€0.0 Mil) but then increased from Jun. 2024 (€0.0 Mil) to Dec. 2024 (€358.0 Mil).

Luye Pharma Group's annual buildings and improvements increased from Dec. 2022 (€241.5 Mil) to Dec. 2023 (€272.1 Mil) and increased from Dec. 2023 (€272.1 Mil) to Dec. 2024 (€358.0 Mil).

Luye Pharma Group Buildings And Improvements Historical Data

The historical data trend for Luye Pharma Group's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luye Pharma Group Buildings And Improvements Chart

Luye Pharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

188.68

232.83

241.53

272.10

358.04

Luye Pharma Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial															241.53	-	272.10	-	358.04

Luye Pharma Group Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Luye Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luye Pharma Group Ltd (FRA:LUP) » Definitions » Buildings And Improvements

Traded in Other Exchanges

LYPHF:USA 02186:Hong Kong

Address

Hongqiao Road 1438, 22/F, Gubei International Fortune Center II, Changning District, Shanghai, CHN, 264003

Website

https://www.luye.cn

Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs, Central nervous system drugs and others. It derives maximum revenue from the sale of Oncology drugs.

Luye Pharma Group Headlines

No Headlines